InvestorsHub Logo
Followers 2
Posts 62
Boards Moderated 0
Alias Born 07/02/2013

Re: medchem post# 7910

Thursday, 04/23/2020 12:54:07 PM

Thursday, April 23, 2020 12:54:07 PM

Post# of 16706
For some reason the Financial Times link is broken so here's an excerpt

https://www.ft.com/content/0a4872d1-4cac-4040-846f-ce32daa09d99

Gilead antiviral drug remdesivir flops in first trial
Financial Times
Donato Paolo Mancini in London and Hannah Kuchler in New York
,Financial Times•April 23, 2020
A potential antiviral drug for the coronavirus has flopped in its first randomised clinical trial, disappointing scientists and investors who had high hopes for remdesivir, according to draft documents published accidentally by the World Health Organization and seen by the Financial Times. The Chinese trial showed remdesivir — developed by California-based Gilead Sciences — did not improve patients’ condition or reduce the pathogen’s presence in the bloodstream. Gilead warned that the post included “inappropriate characterisations of the study”.